Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Second time lucky for Takeda’s obesity drug

FDA approves Contrave three years after initial rejection

- PMLiVE

Baxter names biopharma spin-off Baxalta

Will separate from medical technology business

EU flag

Lantus faces first biosimilar rival in Europe

Sanofi prepares for insulin challenge from Boehringer and Lilly

- PMLiVE

Liberation strengthens team with new member

Edward Mullin has been appointed as account coordinator

- PMLiVE

Pharma spent $342m on journal advertising in first half of 2014

J&J led spending and Invokana was most advertised brand

- PMLiVE

Bayer partners with Glamour on female empowerment

Campaign to support the contraception Skyla

Pharma deals during August 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for August 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

FDA panel votes against Actavis hypertension combo

Places a question mark over the combination of Bystolic and Diovan

National Institute for Health and Care Excellence NICE logo

NICE wants greater access to clinical data

Will turn to European regulators if companies fail to provide information

- PMLiVE

UK wants pharmacists to support better use of drugs

Lord Howe says current procedures are flawed and community pharmacy can help

- PMLiVE

Liraglutide seems effective in obesity, says FDA reviewer

Novo Nordisk drug is already successful diabetes treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links